Aquestive Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Expects to submit IND application for AQST-108 (epinephrine) in second quarter 2020 and commence pharmacokinetics (PK) clinical trials before end of 2020 FDA sets Libervant™ (diazepam) Buccal Film PDUFA goal date of September 27, 2020 Reported full year …